Thomas Jefferson University

Daniel Kremens

TitleAssoc Professor
InstitutionThomas Jefferson University
DepartmentNeurology
Address900 Walnut Street
Philadelphia PA 19107
Phone215-503-2724
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Isaacson SH, Dewey R, Hauser RA, Kremens D, Kumar R, Lew M, Ondo W, Pagan F, Lyons KE, Pahwa R. Apomorphine titration with and without anti-emetic pretreatment in patients with Parkinson's disease experiencing OFF episodes: A modified Delphi panel. Clin Park Relat Disord. 2024; 11:100264. PMID: 39175580.
      Citations:    
    2. Isaacson SH, Kremens D, Torres-Yaghi Y, Stocchi F, Antonini A. Importance of time to ON versus wearing OFF in total daily OFF time experienced by patients with Parkinson's disease. Parkinsonism Relat Disord. 2023 09; 114:105495. PMID: 37517986.
      Citations:    
    3. Pahwa R, Pagan FL, Kremens DE, Saint-Hilaire M. Clinical Use of On-Demand Therapies for Patients with Parkinson's Disease and OFF Periods. Neurol Ther. 2023 Aug; 12(4):1033-1049. PMID: 37221354.
      Citations:    
    4. Isaacson SH, Achari M, Bhidayasiri R, Comella C, Farmer JG, Gupta F, Jones S, Kreitzman D, Kremens D, Lewis SJG, Poewe W, Tolosa E, Campos C, Gibbs SN, Broder MS. Expert Consensus on the Use of On-Demand Treatments for OFF Episodes in Parkinson's Disease: A Modified Delphi Panel. Mov Disord Clin Pract. 2023 Apr; 10(4):652-657. PMID: 37070052.
      Citations:    
    5. Isaacson SH, Dewey RB, Pahwa R, Kremens DE. How to manage the initiation of apomorphine therapy without antiemetic pretreatment: A review of the literature. Clin Park Relat Disord. 2023; 8:100174. PMID: 36691604.
      Citations:    
    6. Citrome L, Isaacson SH, Larson D, Kremens D. Tardive Dyskinesia in Older Persons Taking Antipsychotics. Neuropsychiatr Dis Treat. 2021; 17:3127-3134. PMID: 34703232.
      Citations:    
    7. Hauser RA, Mehta SH, Kremens D, Chernick D, Formella AE. Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson's Disease and Dyskinesia. Neurol Ther. 2021 May 22. PMID: 34024025.
      Citations:    
    8. Das S, Matias CM, Ramesh S, Velagapudi L, Barbera JP, Katz S, Baldassari MP, Rasool M, Kremens D, Ratliff J, Liang TW, Wu C. Capturing Initial Understanding and Impressions of Surgical Therapy for Parkinson's Disease. Front Neurol. 2021; 12:605959. PMID: 33746873.
      Citations:    
    9. McEvoy JP, Kremens DE. Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and Schizophrenia. J Clin Psychiatry. 2020 Jan 28; 81(1). PMID: 31995674.
      Citations:    
    10. Kremens DE. Treatment Strategies for Tardive Dyskinesia. J Clin Psychiatry. 2019 Dec 24; 81(1). PMID: 31880872.
      Citations:    
    11. Kremens DE. Earlier Diagnosis of Tardive Dyskinesia. J Clin Psychiatry. 2019 Dec 10; 81(1). PMID: 31846242.
      Citations:    
    12. Hauser RA, Sutherland D, Madrid JA, Rol MA, Frucht S, Isaacson S, Pagan F, Maddux BN, Li G, Tse W, Walter BL, Kumar R, Kremens D, Lew MF, Ellenbogen A, Oguh O, Vasquez A, Kinney W, Lowery M, Resnick M, Huff N, Posner J, Ballman KV, Harvey BE, Camilleri M, Zasloff M, Barbut D. Targeting neurons in the gastrointestinal tract to treat Parkinson's disease. Clin Park Relat Disord. 2019; 1:2-7. PMID: 34316590.
      Citations:    
    13. Monti DA, Zabrecky G, Kremens D, Liang TW, Wintering NA, Bazzan AJ, Zhong L, Bowens BK, Chervoneva I, Intenzo C, Newberg AB. N-Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson's Disease. Clin Pharmacol Ther. 2019 Jun 17. PMID: 31206613.
      Citations:    
    14. Black KJ, Nasrallah H, Isaacson S, Stacy M, Pahwa R, Adler CH, Alva G, Cooney JW, Kremens D, Menza MA, Meyer JM, Patkar AA, Simuni T, Morrissette DA, Stahl SM. Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus. CNS Spectr. 2019 Jun 11; 1-2. PMID: 31182180.
      Citations:    
    15. Hauser RA, Kremens DE, Elmer LW, Kreitzman DL, Walsh RR, Johnson R, Howard R, Nguyen JT, Patni R. Prevalence of Dyskinesia and OFF by 30-Minute Intervals Through the Day and Assessment of Daily Episodes of Dyskinesia and OFF: Novel Analyses of Diary Data from Gocovri Pivotal Trials. J Parkinsons Dis. 2019; 9(3):591-600. PMID: 31081793.
      Citations:    
    16. Black KJ, Nasrallah H, Isaacson S, Stacy M, Pahwa R, Adler CH, Alva G, Cooney JW, Kremens D, Menza MA, Meyer JM, Patkar AA, Simuni T, Morrissette DA, Stahl SM. Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus. CNS Spectr. 2018 Dec; 23(6):402-413. PMID: 30588905.
      Citations:    
    17. Gupta F, Kremens D, Vernino S, Karabin B. Erratum to: Managing neurogenic orthostatic hypotension in a patient presenting with pure autonomic failure who later developed Parkinson disease. Clin Auton Res. 2017 Dec; 27(6):429. PMID: 28889358.
      Citations:    
    18. Gupta F, Kremens D, Vernino S, Karabin B. Managing neurogenic orthostatic hypotension in a patient presenting with pure autonomic failure who later developed Parkinson disease. Clin Auton Res. 2017 Jul; 27(Suppl 1):9-11. PMID: 28699048.
      Citations:    
    19. Kremens D, Lew M, Claassen D, Goodman BP. Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease. Clin Auton Res. 2017 Jul 03. PMID: 28674867.
      Citations:    
    20. Lew M, Kremens D. Differential diagnosis of suspected neurogenic orthostatic hypotension in a patient with Parkinson disease. Clin Auton Res. 2017 Jul 03. PMID: 28674866.
      Citations:    
    21. Vernino S, Lew M, Kremens D. Managing supine hypertension in a patient with non-diabetic autonomic neuropathy receiving droxidopa for neurogenic orthostatic hypotension. Clin Auton Res. 2017 Jun 16. PMID: 28623420.
      Citations:    
    22. Hermanowicz N, Alva G, Pagan F, Espay AJ, Patel A, Madrid KC, Kremens D, Kenney J, Arquette S, Tereso G, Lopes M, Farnum C. The Emerging Role of Pimavanserin in the Management of Parkinson's Disease Psychosis. J Manag Care Spec Pharm. 2017 Jun; 23(6-b Suppl):S2-S8. PMID: 28636480.
      Citations:    
    23. Isaacson SH, Fisher S, Gupta F, Hermanowicz N, Kremens DE, Lew MF, Marek K, Pahwa R, Russell DS, Seibyl J. Clinical utility of DaTscan™ imaging in the evaluation of patients with parkinsonism: a US perspective. Expert Rev Neurother. 2016 Nov 23; 1-7. PMID: 27813429.
      Citations:    
    24. Monti DA, Zabrecky G, Kremens D, Liang TW, Wintering NA, Cai J, Wei X, Bazzan AJ, Zhong L, Bowen B, Intenzo CM, Iacovitti L, Newberg AB. N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line Data. PLoS One. 2016; 11(6):e0157602. PMID: 27309537.
      Citations:    
    25. Kremens D, Hauser RA, Dorsey ER. An update on Parkinson's disease: improving patient outcomes. Am J Med. 2014 Jan; 127(1):S3. PMID: 24384115.
      Citations:    
    26. Lee EB, Russ J, Jung H, Elman LB, Chahine LM, Kremens D, Miller BL, Branch Coslett H, Trojanowski JQ, Van Deerlin VM, McCluskey LF. Topography of FUS pathology distinguishes late-onset BIBD from aFTLD-U. Acta Neuropathol Commun. 2013 May 9; 1(9):1-11. PMID: 24027631.
      Citations:    
    27. Boland T, Strause J, Hu M, Santamaria D, Liang TW, Kremens D, Sergott R, Moussouttas M. Posterior Reversible Encephalopathy Syndrome Presenting as Opsoclonus-Myoclonus. Neuroophthalmology. 2012 Oct; 36(4):149-152. PMID: 23125471.
      Citations:    
    28. Roshal D, Gutierrez C, Brock D, Kremens D. Pearls & Oy-sters: fibrocartilaginous embolism myelopathy. Neurology. 2010 Feb 16; 74(7):e21-3. PMID: 20157153.
      Citations:    
    29. Lai M, Hughes EG, Peng X, Zhou L, Gleichman AJ, Shu H, Matà S, Kremens D, Vitaliani R, Geschwind MD, Bataller L, Kalb RG, Davis R, Graus F, Lynch DR, Balice-Gordon R, Dalmau J. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol. 2009 Apr; 65(4):424-34. PMID: 19338055.
      Citations:    
    30. Amorosa V, Kremens D, Wolfe MS, Flanigan T, Cahill KM, Judy K, Kasner S, Blumberg E. Schistosoma mansoni in family 5 years after safari. Emerg Infect Dis. 2005 Feb; 11(2):339-41. PMID: 15759334.
      Citations:    
    Kremens's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (59)
    Explore
    _
    Co-Authors (11)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _